Francesca Scarpitta Joins Cerbios as Director of HPAI Manufacturing Units
24.01.2019 - Cerbios has appointed Francesca Scarpitta as director of the company’s high potency active ingredients (HPAIs) production units.
"Dr. Scarpitta brings in a strong expertise and knowledge in the transfer of API manufacturing from R&D. Scale-up improvements following the development of the HPAI from clinical to commercial scale is one of her key competences,“ said Gabriel Haering, CEO of Cerbios.
Scarpitta holds a PhD in organic chemistry at the University of Pavia, Italy. Since 2000 she held various positions in the API industry in Italy and in Israel.